Clinical improvement with furosemide supports TACO and distinguishes from TRALI
Caution: diuretics contraindicated if TRALI is primary diagnosis (may worsen hypotension)
Restrictive transfusion strategy evidence
Hb threshold 70 g/L (7 g/dL) for most non-cardiac, non-obstetric patients
NEJM 2017 (Carson et al): restrictive thresholds reduce transfusion burden and complications
Single-unit strategy with re-evaluation reduces total transfusion exposure
NIV evidence in cardiogenic pulmonary edema
NIV (CPAP or BiPAP) reduces intubation rates in acute cardiogenic pulmonary edema
Applicable to TACO as the mechanism is identical to CHF-related pulmonary edema
Prevention evidence
Pre-transfusion furosemide: logical but lacks high-quality RCT evidence in TACO prevention
Slow infusion rate (3-4 hours per unit) supported by physiologic rationale and guidelines
Single-unit strategy: reassessment between units reduces cumulative volume overload
ICD-10 classification
T80.89XA: Other complications of transfusion, initial encounter
E87.70: Fluid overload, unspecified (may be used in conjunction)
Patient Discharge Instructions
copy discharge instructions
What happened to you
You had a reaction to a blood transfusion called TACO (Transfusion-Associated Circulatory Overload)
This reaction caused fluid to build up in your lungs, making it hard to breathe
TACO happens when the heart temporarily cannot handle the extra fluid from the transfusion
You were treated with oxygen and a water pill (diuretic) to remove the extra fluid
What to expect at home
Most people feel much better within 24-48 hours after treatment
You may notice increased urination for several hours after your diuretic treatment
Mild fatigue is normal after this reaction
Do not restrict fluids excessively at home unless specifically instructed
Your medications
Take all prescribed medications as directed
If you were prescribed a diuretic (water pill), take it at the same time each day
Do not stop your heart or kidney medications without speaking to your doctor
Weigh yourself every morning and call your doctor if you gain more than 1-2 kg in 24 hours
Future transfusions
Tell every healthcare provider about your history of TACO before any future transfusion
Your chart has been flagged so future transfusions will be given more slowly
You may receive a diuretic before future transfusions to prevent recurrence
Your blood bank has been notified about this reaction
Return to the emergency department immediately for
Difficulty breathing or shortness of breath
Chest pain or chest tightness
New or worsening cough
Feeling your heart racing or pounding
Swelling in your legs or feet that is getting worse
Coughing up pink or frothy sputum
Feeling dizzy or faint
Confusion or difficulty thinking clearly
Follow-up appointments
Follow-up with your family doctor within 1 week
Heart specialist (cardiologist) follow-up if new heart problems were found
Kidney specialist (nephrologist) follow-up if kidney disease is present
Bring this discharge summary to all follow-up appointments
References
Guidelines and key sources
Semple JW, Rebetz J, Kapur R. Transfusion-Associated Circulatory Overload and Transfusion-Related Acute Lung Injury. Blood. 2019. PMID: 30808638
Comprehensive review of TACO and TRALI mechanisms, differentiation, and management
Bosboom JJ, Klanderman RB, Migdady Y, et al. Transfusion-Associated Circulatory Overload: A Clinical Perspective. Transfusion Medicine Reviews. 2019. PMID: 30853167
Clinical perspective including incidence 1-12% in at-risk populations
Delaney M, Wendel S, Bercovitz RS, et al. Transfusion Reactions: Prevention, Diagnosis, and Treatment. Lancet. 2016. PMID: 27083327
Comprehensive review of transfusion reactions including TACO management
Bulle EB, Klanderman RB, Pendergrast J, et al. The Recipe for TACO: Pathophysiology and Mitigation Strategies. Blood Reviews. 2022. PMID: 34627651
Two-hit model of TACO pathogenesis; 50% of cases after single unit
Wiersum-Osselton JC, Whitaker B, Grey S, et al. Revised International Surveillance Case Definition of TACO. Lancet Haematology. 2019. PMID: 31080132
Current international consensus diagnostic criteria for TACO
Roubinian NH, Hendrickson JE, Triulzi DJ, et al. Contemporary Risk Factors and Outcomes of TACO. Critical Care Medicine. 2018. PMID: 29300236
Sarai M, Tejani AM. Loop Diuretics for Patients Receiving Blood Transfusions. Cochrane Database of Systematic Reviews. 2015
Systematic review supporting prophylactic loop diuretics in at-risk transfusion recipients
Klanderman RB, Bosboom JJ, Migdady Y, et al. TACO - A Systematic Review of Diagnostic Biomarkers. Transfusion. 2019. PMID: 30488959
NT-proBNP ratio > 1.5, post-transfusion BNP thresholds
Alam A, Lin Y, Lima A, Hansen M, Callum JL. The Prevention of Transfusion-Associated Circulatory Overload. Transfusion Medicine Reviews. 2013. PMID: 23465703
Prevention strategies including pre-transfusion diuretics and single-unit strategy
Carson JL, Triulzi DJ, Ness PM. Indications for and Adverse Effects of Red-Cell Transfusion. NEJM. 2017. PMID: 28121507
Restrictive transfusion thresholds; TACO as major adverse effect
Gajic O, Gropper MA, Hubmayr RD. Pulmonary Edema After Transfusion: How to Differentiate TACO From TRALI. Critical Care Medicine. 2006. PMID: 16617253
Fluid protein/serum protein ratio < 0.65 for TACO, > 0.75 for TRALI
Vlaar APJ, Zwaginga JJ, Wiersum-Osselton JC. How I Diagnose and Treat Cardiorespiratory Complications of Transfusion. Blood. 2025. PMID: 39374519
Contemporary approach to cardiorespiratory transfusion reactions
Lowack J, Vlaar AP, Klanderman RB, Peters AL. Pulmonary Transfusion Reactions as an Immunological Spectrum Disorder. Current Opinion in Immunology. 2025. PMID: 41202391
TACO/TRALI overlap as spectrum disorder
Goel R, Tobian AAR, Shaz BH. Noninfectious Transfusion-Associated Adverse Events and Their Mitigation Strategies. Blood. 2019. PMID: 30808635
Hemovigilance reporting and mitigation strategies
SymptomDx is an educational tool for medical professionals. It does not replace clinical judgment. Verify all clinical data and drug dosages with authoritative sources.